Table 3.

Second‐Stage Cox Proportional Hazard Models: Effect of Sulfonylureas (SU) on Mortality, Ambulatory Care–Sensitive Condition (ACSC) Hospitalization, and Cardiovascular Outcomes (n = 80,936)

	Hazard Ratio	P < |t|	95% Confidence Interval
All‐cause mortality	1.50	0.014	1.09–2.09
ACSC hospitalization	1.68	<0.001	1.31–2.15
Stroke or heart attack	1.15	0.457	0.80–1.66

Models include baseline demographics, Elixhauser comorbidities, Young severity index, HbA_1c, BMI, microalbumin, serum creatinine, provider quality controls, year fixed effects, and Veterans Affairs Medical Center random effects.

Source. Excerpted from Prentice et al. (2014, table 4).